135 related articles for article (PubMed ID: 29273680)
1. IGF system in sarcomas: a crucial pathway with many unknowns to exploit for therapy.
Mancarella C; Scotlandi K
J Mol Endocrinol; 2018 Jul; 61(1):T45-T60. PubMed ID: 29273680
[TBL] [Abstract][Full Text] [Related]
2. The insulin-like growth factor system and sarcomas.
Rikhof B; de Jong S; Suurmeijer AJ; Meijer C; van der Graaf WT
J Pathol; 2009 Mar; 217(4):469-82. PubMed ID: 19148905
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas.
Sekyi-Otu A; Bell RS; Ohashi C; Pollak M; Andrulis IL
Cancer Res; 1995 Jan; 55(1):129-34. PubMed ID: 7805022
[TBL] [Abstract][Full Text] [Related]
4. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
Camidge DR; Dziadziuszko R; Hirsch FR
Clin Lung Cancer; 2009 Jul; 10(4):262-72. PubMed ID: 19632946
[TBL] [Abstract][Full Text] [Related]
5. A characteristic signature of insulin-like growth factor (IGF) axis expression during osteogenic differentiation of human dental pulp cells (hDPCs): Potential co-ordinated regulation of IGF action.
Al-Khafaji H; Noer PR; Alkharobi H; Alhodhodi A; Meade J; El-Gendy R; Oxvig C; Beattie J
Growth Horm IGF Res; 2018; 42-43():14-21. PubMed ID: 30071469
[TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor system in cancer.
Weroha SJ; Haluska P
Endocrinol Metab Clin North Am; 2012 Jun; 41(2):335-50, vi. PubMed ID: 22682634
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the expression and role of IGF pathway biomarkers in human sarcomas.
Lin F; Shen Z; Xu X; Hu BB; Meerani S; Tang LN; Zheng SE; Sun YJ; Min DL; Yao Y
Int J Immunopathol Pharmacol; 2013; 26(1):169-77. PubMed ID: 23527719
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
[TBL] [Abstract][Full Text] [Related]
9. A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells.
Chen Z; Liu J; Chu D; Shan Y; Ma G; Zhang H; Zhang XD; Wang P; Chen Q; Deng C; Chen W; Dimitrov DS; Zhao Q
Int J Biol Sci; 2018; 14(7):799-806. PubMed ID: 29910690
[TBL] [Abstract][Full Text] [Related]
10. The insulin-like growth factor pathway in lung cancer.
Dziadziuszko R; Camidge DR; Hirsch FR
J Thorac Oncol; 2008 Aug; 3(8):815-8. PubMed ID: 18670298
[TBL] [Abstract][Full Text] [Related]
11. The IGF system in the neonatal ovine uterus.
Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
[TBL] [Abstract][Full Text] [Related]
12. The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis.
Tzanakakis GN; Giatagana EM; Berdiaki A; Spyridaki I; Hida K; Neagu M; Tsatsakis AM; Nikitovic D
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069554
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options.
Mancarella C; Morrione A; Scotlandi K
Cells; 2021 Aug; 10(8):. PubMed ID: 34440844
[TBL] [Abstract][Full Text] [Related]
14. Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.
van Maldegem AM; Bovée JV; Peterse EF; Hogendoorn PC; Gelderblom H
Eur J Cancer; 2016 Jan; 53():171-80. PubMed ID: 26765686
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
16. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
17. A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer.
Belfiore A; Malaguarnera R; Nicolosi ML; Lappano R; Ragusa M; Morrione A; Vella V
Cell Adh Migr; 2018; 12(4):305-314. PubMed ID: 29486622
[TBL] [Abstract][Full Text] [Related]
18. Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer.
Philippou A; Christopoulos PF; Koutsilieris DM
Mutat Res Rev Mutat Res; 2017; 772():105-122. PubMed ID: 28528684
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
[TBL] [Abstract][Full Text] [Related]
20. The pregnancy-associated plasma protein A and insulin-like growth factor system in response to cigarette smoking.
Chelchowska M; Maciejewski T; Gajewska J; Ambroszkiewicz J; Laskowska-Klita T; Leibschang J
J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2377-80. PubMed ID: 22630333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
